Investing in Singapore’s Straits Times Index (STI) gives investors direct exposure to high-performing local banks, REITs, and household names – but is that all?

In a volatile environment, Singapore continues to benefit from its stability, and its global leadership as an energy, finance and transport hub. With the STI recently notching new highs and local bourse reform underway, what is the strategic role for Singapore-listed companies in a diversified portfolio?

Join us in this upcoming live webinar to learn more about Endowus’ first index fund tracking the STI.  Our CIO, Hugh Chung, will be joined by Sunny Leung, Head of Amundi ETF, Indexing and Smart Beta Sales, Asia ex-Japan and David Poh,
Head of Investment and ESG Strategies, South Asia, to discuss:

1. The case for considering Singapore-listed companies today

2. Characteristics of the new Amundi Singapore StraitsTimes Fund available only on Endowus

3. How the index tracker fits in along-term investor’s portfolio

About Amundi Singapore Straits Times Fund

 1. Access Singapore’s top 30 listed companies‍

Amid global volatility, Singapore’s economy has been a pillar of stability. Invest in the largest listed companies such as DBS, OCBC, and Capitaland, which have historically delivered yields*.

 2. Low cost access to diversification

Benefit from the lowest management fee at just 0.15%, with no transaction or sales fees**

‍ 3. Exclusively available on Endowus

Access the Amundi Singapore Straits Times Fund only on Endowus. Available for Cash investments.
‍

About the speakers

Hugh Chung‍
Chief Investment Officer
Endowus

Hugh leads the integration of investment functions and strategies across the Endowus Group, comprising the Endowus digital platform, Endowus Private Wealth, and Carret Private. He oversees the centralised Investment Office, which provides group strategic direction on the expert curation and management of all investment solutions across public and private markets, for individual and institutional investors in Singapore and Hong Kong.

Sunny Leung
Head of ETF, Indexing and Smart Beta Sales for Asia ex Japan
Amundi

Before being appointed Head of ETF, Indexing and Smart Beta Sales for Asia ex Japan in October 2023, Sunny Leung was Head of ETF, Indexing, and Smart Beta Sales in North Asia from 2017 to 2019. He then led the South Asia ETF Indexing and Smart Beta Sales team from 2019 to 2023. He and his team focus on ETF business development across both institutional and wealth segments in Asia ex Japan.

Before joining Amundi, Sunny served at State Street Global Advisors Singapore, overseeing business development and client services for SPDR ETFs. He also held various ETF sales and marketing positions in Asia with Vanguard Investment Hong Kong, Credit Suisse Asset Management, and Lyxor Asset Management since 2007.

David Poh
Head of Investment and ESG Strategies, South Asia
Amundi

David POH has re-joined the Emerging Markets team in South Asia, following his role as Head of Research at Amundi BOC (Bank of China) Wealth Management. He was based in Shanghai for close to 2 years, where he led a team of 11 analysts covering domestic Chinese equities and credits. He first joined Amundi in February 2018 as Head of Equities based in Singapore, and was subsequently appointed Head of Investments for Singapore and Head of Equities South Asia in November 2019.

David started his professional career in 1996, and worked in a number of leading multinational financial institutions, including Portfolio Manager for Alliance Bernstein Asset Management, Senior Asian Equity Analyst for Pioneer Investments, and Deputy CIO for Credit Suisse Asset Management.

‍

Disclaimers:
*Source: SGX, updated as of Mar 2025, unless otherwise stated. https://www.sgx.com/campaign/sti
**Lowest TER in comparison to other STI ETFs in the markets. An Endowus fee applies

This document contains information about Amundi Singapore Straits Times (the “Fund”), a sub-fund of Amundi Index Solutions, an undertaking for collective investment in transferable securities existing under Part 1 of the Luxembourg law of 17 December 2010, organised as a société anonyme and qualifying as a société d'investissement à capital variable under the laws of Luxembourg and registered with the Luxembourg Trade and Companies Register under number B206810 and having its registered office at 5, allee Scheffer, L-2520 Luxembourg. The management company of the Fund is Amundi Luxembourg S.A., 5, allée Scheffer, L-2520 Luxembourg and the Singapore Representative of the Fund is Amundi Singapore Limited (Registration No. 198900774E), 80 Raffles Place, UOB Plaza 1, #23-01, Singapore 048624 (Amundi Luxembourg S.A. and/or its affiliated companies, including without limitation Amundi Singapore Limited, being hereinafter referred to individually or jointly as "Amundi”). Amundi Singapore Limited is regulated by the Monetary Authority of Singapore.

This is a marketing communication. Investors should read the Singapore Prospectus and the Product Highlights Sheet before deciding to invest in the Fund. The share classes / classes of the Fund available for offer to the retail public in Singapore are set out in the Singapore Prospectus and the Product Highlights Sheet, which together with the latest annual and semi-annual reports (if any) may be obtained, free of charge, at the registered office of the Singapore Representative of the Fund or at www.amundi.com.sg or the Fund’s authorised distributors.

This document is for information purposes only, is not a recommendation, financial analysis or advice, and does not constitute a solicitation, invitation or offer to purchase or sell the Fund in any jurisdiction where such offer, solicitation or invitation would be unlawful. This information is not for distribution and does not constitute an offer to sell or the solicitation of any offer to buy any securities or services in the United States or in any of its territories or possessions subject to its jurisdiction to or for the benefit of any U.S. Person (as this term is defined in SEC Regulation S under the U.S. Securities Act of 1933 and in the Singapore Prospectus of the Fund). The Fund is not registered in the United States under the Investment Company Act of 1940 and shares of the Fund are not registered in the United States under the Securities Act of 1933. Accordingly, this document is for distribution or to be used solely in jurisdictions where it is permitted and to persons who may receive it without breaching applicable legal or regulatory requirements, or that would require the registration of Amundi or its affiliates in these countries.

Past performance and any forecasts made are not indicative of future performance of the Fund. Please note that distribution/dividends (if applicable) are not guaranteed unless otherwise stated in the dividend policy for the relevant share class / class contained in the Singapore Prospectus. Investors should review the relevant dividends disclosure report (if applicable) found on www.amundi.com.sg. Any opinion or view presented is subject to change without notice. The information in this document is intended for general circulation without taking into account the specific investment objectives, financial situation or particular needs of any particular investor. An investor may wish to seek advice from a financial adviser regarding the suitability of the Fund, taking into account the specific investment objectives, financial situation or particular needs of any person in receipt of the recommendation, before making a commitment to purchase shares in the Fund.

Where applicable and contemplated in the Singapore Prospectus, the Fund may invest in financial derivatives as part of its strategy, and a material portion of the returns may be generated from financial derivative strategies. In such scenarios, the Fund will be subject to risks associated with such investments as further detailed in the Singapore Prospectus. Additional risk factors are described in the Singapore Prospectus. Investments in the Fund are subject to investment risks, including the possible loss of the principal amount invested. Such activities may not be suitable for everyone. Value of the shares in the Fund and the income accruing to the shares, if any, may fall or rise. Any forecast, projection or target is indicative only and is not guaranteed in any way. Such information is solely indicative and may be subject to modification from time to time.

It is the responsibility of investors to read the legal documents in force in particular the current Singapore Prospectus of the Fund. Subscriptions in the Fund will only be accepted on the basis of their latest prospectus available in English and/or the Product Highlights Sheet. A summary of information about investors’ rights and collective redress mechanisms can be found in English on the regulatory page at https://about.amundi.com/Metanav-Footer/Footer/Quick-Links/Legal-documentation.

Information on sustainability-related aspects (if applicable) can be found at https://about.amundi.com/Metanav-Footer/Footer/Quick-Links/Legal-documentation.

The information contained in this document is as at 30 June 2025 except where otherwise stated. The information contained in this document has been obtained from sources believed to be reliable but has not been independently verified, although Amundi and its affiliated companies believe it to be fair and not misleading. Amundi does not accept any liability whatsoever whether direct or indirect that may arise from the use of information contained in this document. Amundi and its associates, directors, connected parties and/or employees may from time to time have interests and/or underwriting commitments in the investments mentioned in this document. Amundi does not guarantee that all risks associated to the transactions mentioned herein have been identified, nor does it provide advice as to whether you should enter into any such transaction. Amundi does not make any representation as to the merits, suitability, expected success, or profitability of any such transaction mentioned herein.

Pursuant to the new Guidelines on marketing communications under Regulation (EU) 2019/1156 of 20 June 2019 on cross-border distribution of funds issued by the European Securities and Markets Authority (ESMA), performance returns which are less than 12 months will not be reported for European domiciled funds.

This advertisement or publication has not been reviewed by the Monetary Authority of Singapore.

The information contained shall not be copied, reproduced, modified, translated or distributed without the prior written approval of Amundi.